Biotech

All Articles

Sanofi's $80M bet on Pivot dystrophy medication ends in stage 3 go bust

.Only four months after Sanofi wager $80 thousand in ahead of time money on Key Rehabs' losmapimod, ...

Oncternal share drains 60% among cutbacks, trial firings

.Cancer business Oncternal Therapies is actually folding all its professional trials as well as layi...

Roche is holding out chances that its injectable weight problems prospect can inevitably display 25% weight reduction in late-stage test

.Roche is keeping out hopes that its own injectable obesity prospect might inevitably illustrate 25%...

Novo Nordisk barrages 'outstanding' effective weight loss result for dual-acting dental medicine in early trial

.Novo Nordisk has elevated the lid on a period 1 trial of its dental amylin and also GLP-1 receptor ...

AbbVie takes legal action against BeiGene over blood stream cancer medicine classified information

.Simply a couple of quick full weeks after winning an FDA Fast Track tag for its own investigational...

Lilly supplies one-two strike along with second tranche of beneficial information on every week the hormone insulin prospect

.Shortly after a good records drop for Eli Lilly's efsitora alfa, the Indianapolis-based provider is...

BridgeBio cuts gene treatment budget plan as clinical data let down

.BridgeBio Pharma is slashing its own gene treatment finances and drawing back coming from the modal...

GSK relinquishes HSV injection hopes after stage 2 stop working, yielding race to Moderna, BioNTech

.GSK's try to develop the 1st injection for genital herpes simplex virus (HSV) has ended in failing,...

GSK's long-acting breathing problem drug halved attacks in phase 3

.GSK's long-acting asthma therapy has actually been revealed to cut in half the variety of assaults ...

AstraZeneca, Daiichi unpack Dato-DXd's total survival stop working

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has fallen short to e...